On Monday, Autolus Therapeutics plc ADR (NASDAQ: AUTL) opened higher 6.13% from the last session, before settling in for the closing price of $1.63. Price fluctuations for AUTL have ranged from $1.11 to $2.80 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 21.35%. Company’s average yearly earnings per share was noted -12.14% at the time writing. With a float of $240.34 million, this company’s outstanding shares have now reached $266.14 million.
The extent of productivity of a business whose workforce counts for 647 workers is very important to gauge.
Autolus Therapeutics plc ADR (AUTL) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Autolus Therapeutics plc ADR is 9.70%, while institutional ownership is 51.21%.
Autolus Therapeutics plc ADR (AUTL) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.09 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.24) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -12.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.56% during the next five years compared to 21.35% growth over the previous five years of trading.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Trading Performance Indicators
Check out the current performance indicators for Autolus Therapeutics plc ADR (AUTL). In the past quarter, the stock posted a quick ratio of 5.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.72 in one year’s time.
Technical Analysis of Autolus Therapeutics plc ADR (AUTL)
The latest stats from [Autolus Therapeutics plc ADR, AUTL] show that its last 5-days average volume of 2.56 million was superior to 2.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 68.75%.
During the past 100 days, Autolus Therapeutics plc ADR’s (AUTL) raw stochastic average was set at 40.15%, which indicates a significant decrease from 86.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0996 in the past 14 days, which was lower than the 0.1083 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4878, while its 200-day Moving Average is $1.7171. Now, the first resistance to watch is $1.8100. This is followed by the second major resistance level at $1.8900. The third major resistance level sits at $1.9900. If the price goes on to break the first support level at $1.6300, it is likely to go to the next support level at $1.5300. Assuming the price breaks the second support level, the third support level stands at $1.4500.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Key Stats
There are currently 266,143K shares outstanding in the company with a market cap of 460.42 million. Presently, the company’s annual sales total 10,120 K according to its annual income of -220,660 K. Last quarter, the company’s sales amounted to 21,190 K and its income totaled -79,120 K.
